JBRA Assist. Reprod. 2019;23(1):79-80
LETTER
doi: 10.5935/1518-0557.20180075
1Reproductive Medicine Unit, North Middlesex University Hospital, Old Admin Block, Sterling Way, London N18 1QX, UK
2Homerton Fertility Unit, Homerton University Hospital, Homerton Row, London E9 6SR, UK
Dear Editor,
Prognostic factors in IUI analyses is a subject both topical and of importance if pregnancy rates in IUI are to be improved. Although the recent retrospective study (Sicchieri et al., 2018) aims to decipher the various contributors to IUI pregnancy rates, such as patient age, cause of infertility, ovulation induction method, number of mature follicles and sperm with progressive motility, the overall pregnancy rate of 7.59%/cycle was disappointing and this may give a wrong perception of IUI practice. The UK IUI pregnancy rates averaged around 13.5%/cycle and some clinics exceeding 20%/cycle. It also means that with every 100 women seeking first line treatment as IUI, 25-35% of the cohort will become pregnant (Bahadur et al., 2016a). We even demonstrated how it was possible to overcome the severe oligozoospermic effect by utilising a consecutive ejaculate (Bahadur et al., 2016b). Crucial to IUI success was to switch over to gonadotropin stimulated cycles, aiming for 2-3 follicles, but with a strict cancellation policy to protect the patient from OHSS and multiple births. In more complex and older patients, combination stimulation regimes can be tried. The cost-effective data clearly shows that more pregnancies can occur with gonadotropin stimulated cycles (Peeraer et al., 2018), or where greater than 3 million motile progressive sperm are inseminated. Newer, well-constructed RCT's provide further strong support for using IUI as first treatment option based on high-quality evidence (Bensdorp et al., 2015; Farquhar et al., 2018; Nandi et al., 2017). Sicchieri et al. (2018) rightly draw attention to affordability issues in most parts of the world, and we now know that over 50% of women undergoing IVF do not need IVF (Malchau et al., 2017). The way forward is to achieve IUI pregnancies earlier, paying attention to numerous prognostic factors and tailoring the stimulation method for IUI. In particular, these are associated with the use of gonadotrophin stimulation, having greater than 3 million motile progressive sperm in the insemination, having 2-3 follicles, and above all ensuring safe practice against OHSS and multiple births with a strict cancellation policy in place. Secondly, clinics should monitor their outcomes in real time using a dedicated database. Our proposals should help steer the global use of IUI towards a more effective and efficient first line treatment option.
REFERENCES
Bahadur G, Homburg R, Muneer A, Racich P, Alangaden T, Al-Habib A, Okolo S. First line fertility treatment strategies regarding IUI and IVF require clinical evidence. Hum Reprod. 2016a;31:1141-6.
Medline Crossref
Bahadur G, Almossawi O, IIlahibuccus A, Al-Habib A, Okolo S. Factors Leading to Pregnancies in Stimulated Intrauterine Insemination Cycles and the Use of Consecutive Ejaculations Within a Small Clinic Environment. J Obstet Gynaecol India. 2016b;66:513-20.
Medline Crossref
Bensdorp AJ, Tjon-Kon-Fat RI, Bossuyt PM, Koks CA, Oosterhuis GJ, Hoek A, Hompes PG, Broekmans FJ, Verhoeve HR, de Bruin JP, van Golde R, Repping S, Cohlen BJ, Lambers MD, van Bommel PF, Slappendel E, Perquin D, Smeenk JM, Pelinck MJ, Gianotten J, Hoozemans DA, Maas JW, Eijkemans MJ, van der Veen F, Mol BW, van Wely M. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation. BMJ. 2015;350:g7771.
Medline Crossref
Farquhar CM, Liu E, Armstrong S, Arroll N, Lensen S, Brown J. Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet. 2018;391:441-50.
Medline Crossref
Malchau SS, Henningsen AA, Loft A, Rasmussen S, Forman J, Nyboe Andersen A, Pinborg A. The long-term prognosis for live birth in couples initiating fertility treatments. Hum Reprod. 2017;32:1439-49.
Medline Crossref
Nandi A, Bhide P, Hooper R, Gudi A, Shah A, Khan K, Homburg R. Intrauterine insemination-with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained sub-fertility: a randomized controlled trial. Fertil Steril. 2017;107:1329-35.e2.
Medline Crossref
Peeraer K, Luyten J, Tomassetti C, Verschueren S, Spiessens C, Tanghe A, Meuleman C, Debrock S, Dancet E, D'Hooghe T. Cost-effectiveness of ovarian stimulation with gonadotro-phin and clomiphene citrate in an intrauterine insemination programme for subfertile cou-ples. Reprod Biomed Online. 2018;36:302-10.
Medline Crossref
Sicchieri F, Silva AB, Silva ACJSRE, Navarro PAAS, Ferriani RA, Reis RMD. Prognostic factors in intrauterine insemination cycles. JBRA Assist Reprod. 2018;22:2-7.
Medline Crossref